The Recall Desk
CriticalFDA (Drugs)·D-0019-2017·Announced 2016-10-19

La' Trim Plus Capsules Recalled for Unapproved Active Ingredients

Bee Xtreme LLC is recalling La' Trim Plus dietary supplements because FDA analysis found unapproved drugs sibutramine and phenolphthalein.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

Bee Xtreme LLC is recalling La' Trim Plus Dietary Supplement Capsules, 350 mg, 60 count bottles. The product was manufactured for Timeless Solutions and distributed by BeeXtreme LLC. The recall involves 589 bottles across all lots.

The FDA is classifying this as a Class I recall because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis determined that the capsules contain sibutramine and phenolphthalein, which are unapproved active ingredients in this dietary supplement.

Consumers who have purchased La' Trim Plus capsules should stop using the product and contact Bee Xtreme LLC for further instructions.

The recalled product

Product
La' Trim Plus Dietary Supplement Capsules, 350 mg, 60 count bottles, Manufactured for Timeless Solutions, 1810 E Sahara Ave #100, Las Vegas, Nevada 89104, distributed by BeeXtreme LLC, Punxsutawney PA
Manufacturer
Bee Xtreme
Affected units
589

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Lots

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 3 recalled by Bee Xtreme under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →